Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

NCT07364747 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT07364747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07364747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial
Lead sponsor
Siriraj Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
December 23, 2024
Completion date
March 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin-induced ototoxicity, ototoxicity, ototoxicity, drug-induced, sensorineural hearing loss